Holst JJ - Search Results

1

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.

Tharakan G, Behary P, Wewer Albrechtsen NJ, Chahal H, Kenkre J, Miras AD, Ahmed AR, Holst JJ, Bloom SR, Tan T. Tharakan G, et al. Among authors: holst jj. Eur J Endocrinol. 2017 Dec;177(6):455-464. doi: 10.1530/EJE-17-0446. Epub 2017 Aug 30. Eur J Endocrinol. 2017. PMID: 28855269 Free PMC article.

2

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

Orskov C, Holst JJ, Nielsen OV. Orskov C, et al. Among authors: holst jj. Endocrinology. 1988 Oct;123(4):2009-13. doi: 10.1210/endo-123-4-2009. Endocrinology. 1988. PMID: 2901341

3

Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.

Andreasen JJ, Orskov C, Holst JJ. Andreasen JJ, et al. Among authors: holst jj. Digestion. 1994;55(4):221-8. doi: 10.1159/000201151. Digestion. 1994. PMID: 8063025

4

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.

Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ. Hvidberg A, et al. Among authors: holst jj. Metabolism. 1994 Jan;43(1):104-8. doi: 10.1016/0026-0495(94)90164-3. Metabolism. 1994. PMID: 8289665

5

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA. Willms B, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1996 Jan;81(1):327-32. doi: 10.1210/jcem.81.1.8550773. J Clin Endocrinol Metab. 1996. PMID: 8550773 Clinical Trial.

6

The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.

Toft-Nielson M, Madsbad S, Holst JJ. Toft-Nielson M, et al. Among authors: holst jj. Diabetes. 1996 May;45(5):552-6. doi: 10.2337/diab.45.5.552. Diabetes. 1996. PMID: 8621002

7

No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.

Toft-Nielsen M, Hvidberg A, Hilsted J, Dige-Petersen H, Holst JJ. Toft-Nielsen M, et al. Among authors: holst jj. Diabet Med. 1996 Jun;13(6):544-8. doi: 10.1002/(SICI)1096-9136(199606)13:6<544::AID-DIA129>3.0.CO;2-X. Diabet Med. 1996. PMID: 8799658 Clinical Trial.

8

GLP-1 in NIDDM.

Holst JJ. Holst JJ. Diabet Med. 1996 Sep;13(9 Suppl 6):S156-60. Diabet Med. 1996. PMID: 8894501 Review.

9

Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.

Vaag AA, Holst JJ, Vølund A, Beck-Nielsen HB. Vaag AA, et al. Among authors: holst jj. Eur J Endocrinol. 1996 Oct;135(4):425-32. doi: 10.1530/eje.0.1350425. Eur J Endocrinol. 1996. PMID: 8921824

10

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation.

Wettergren A, Wøjdemann M, Meisner S, Stadil F, Holst JJ. Wettergren A, et al. Among authors: holst jj. Gut. 1997 May;40(5):597-601. doi: 10.1136/gut.40.5.597. Gut. 1997. PMID: 9203936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,781 results

Search Page

Filters